Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Cited by (1,000)

Items 901–1,000 of 1,000

1. Therapeutic Role of Bone Marrow Mesenchymal Stem Cells (BMSCs) in Nonalcoholic Steatohepatitis (NASH) Cirrhosis
   Hai-Tang Jiang, Hao-Ming Ye, Hua-Yang Yu, Yiping Zhu, Mingyu Hu, Manli He, Wenhua Li, Zehui Yu, Qian Yang, Lvqin He et al. · 2024 · Current Stem Cell Research & Therapy
2. Disruption of Melatonin Signaling Leads to Lipids Accumulation in the Liver of Melatonin Proficient Mice
   Varunika Goyal, Gianluca Tosini · 2024 · Journal of Pineal Research
3. Protective Effect of Carvedilol Against Oxidative Stress Induced by Palmitic Acid in Primary Rat Hepatocytes
   Sandra Serna Salas, Turtushikh Damba, Manon Buist‐Homan, Han J. Moshage · 2025 · Cell Biochemistry and Function
4. The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis
   Shubham Kumar Sharma, Anjali Sharma, Parul Gupta, Deepshi Arora, Geeta Deswal, Ajmer Singh Grewal, Devkant Sharma · 2025 · Cardiovascular & Haematological Disorders - Drug Targets
5. Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and hepatitis B virus infection in the intrahepatic and extrahepatic cholangiocarcinoma: a retrospective case-based study in China
   Hasan Md Rasadul, Pengcheng Kang, Jinglin Li, Shihui Ma, Chenjing Duan, Xudong Zhao, Yun-fu Cui · 2025 · Infectious Agents and Cancer
6. Prevalence and risk factors of metabolic associated fatty liver disease in lean patients with bipolar disorder: a retrospective cross-sectional study
   Weihong Lei, Jiahuan Li, Yiyi Liu, Ying Wang, Qing Wu · 2025 · Frontiers in Endocrinology
7. Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression
   Julio Aleman, Lawrence A. Vernetti, Mark E. Schurdak, Richard DeBiasio, Greg LaRocca, Vijay K. Yechoor, D. Lansing Taylor, Andrew M. Stern, Mark T. Miedel · 2026 · BMC Biotechnology
8. Integrated bioinformatics and in vitro validation reveal TUBB as a core gene and therapeutic target in NAFLD-related hepatocellular carcinoma
   Zheng Luo, Yongqiang Zhang, Chengbin Guo, Lijuan Chen, Qian Ma, Yanqiu Wang, Yuqin Tang, Jiaqiang Zhang, Chuanliang Chen · 2025 · International Journal of Biological Macromolecules
9. Cichoriin suppresses hepatic lipid accumulation and fibrosis in mice metabolic dysfunction associated steatohepatitis via the AMPK pathway
   Yao Zhao, Xinjie Luo, Tian Li, Xinling Wang, Jianhua Yang, Junping Hu · 2025 · Biochemical Pharmacology
10. Association Between ‘Weekend Warrior’ and Other Leisure-Time Physical Activity Patterns and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Data from the Korea National Health and Nutrition Examination Survey (2014–2023)
    Yun Sung Kim, Seo Yeong An, Justin Y. Jeon, Dong Hoon Lee · 2025 · Applied Sciences
11. Harnessing the River Red Gum: A promising nano-delivery for optimal therapeutic effect against HFD-induced non-alcoholic steatohepatitis (NASH) in rats
    Dina Mostafa Mohammed, Doha H. Abou Baker, Reda M. S. Korany · 2026 · Food Bioscience
12. Dysregulated Lipid Metabolism in Hepatocellular Carcinoma: Mechanisms and Therapeutic Strategies
    Yi Yi, Xi Liu, Xi Zhang, Yongsheng Li, Huakan Zhao · 2026 · MedComm – Oncology
13. Berberine Alleviates Hepatic Steatosis by Restoring CPT1α Histone Acetylation and Modulating HDAC2/SIRT2
    Chenye Shi, Shuai Ma, Hua Bian, Qiong Liu, Huandong Lin, Xin Gao, Haifu Wu, Hongmei Yan, Xinxia Chang · 2026 · Iranian journal of pharmaceutical research
14. ZRSR1 protects against obesity-associated hepatic lipogenesis independent of minor intron splicing
    Yinkun Fu, Hongyong Song, Yinglin Han, Ding Chen, Wenyan Li, Ying Sun, Ming He, Xin Peng, Xu Zhao · 2026 · Life Metabolism
15. Molecular Pathophysiology of Hepatocellular Carcinoma: From Metabolic Inflammation to Therapeutic Targets
    Sara M. Azzam, Alexandra J Straus, Can E. Senkal, Devanand Sarkar · 2026 · Cancers
16. Liver transplantation for fatty liver disease
    John J. Fung · 2010 · Journal of Digestive Diseases
17. Endocannabinoids in the pathophysiology of obesity – The liver
    Ariane Mallat, Sophie Lotersztajn · 2010 · Drug Discovery Today Disease Mechanisms
18. Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) in community-dwellers of Beijing, China
    G Li, Zhaojun Cheng, C Wang, A Liu, Yonghan He, Pufeng Wang · 2013 · OA Evidence-Based Medicine
19. Hepatic lipid metabolism and non-alcoholic fatty liver disease
    Yulan Qu, Ze‐Guang Han · 2017 · Scientia Sinica Vitae
20. Animal Models of Obesity Characterized by Non-alcoholic Fatty Liver Disease (NAFLD)
    M. R. Fernandes, P. S. Figueiredo, Karoline SilvaRezende, Karine de Cássia Freitas, P. Hiane, R. A. Guimarães · 2017 · InTech eBooks
21. Impaired base excision repair is related to the pathogenesis of non-alcoholic fatty liver disease
    Sylwia Ziółkowska, Piotr Lech Czarny, Janusz Szemraj · 2020 · Acta Universitatis Lodziensis Folia Biologica et Oecologica
22. Kronik viral hepatitli olgularda kombine non-alkolik yağlı karaciğer hastalığının sıklığı ve önemi
    Ferah Tuncel, Aslıhan Duman · 2021 · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi
23. Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study
    Sara Ghoneim, Aneesh Dhorepatil, Aun Raza Shah, Ganesh Ram, Subhan Ahmad, Chang Kim, Imad Asaad · 2020 · World Journal of Hepatology
24. E4orf1 Prevents Progression of Fatty Liver Disease in Mice on High Fat Diet
    Rownock Afruza, Nikhil V. Dhurandhar, Vijay K. Hegde · 2022 · International Journal of Molecular Sciences
25. Epigenetics of NAFLD and NASH
    Johanna Kay DiStefano, Xiumei Wu · 2023 · Elsevier eBooks
26. NAFLD, the hepatic manifestation of the metabolic syndrome
    Tirthankar Chaudhury, Lucia Brodosi, Giulio Marchesini, Sandip Kumar Mitra, Maria Letizia Petroni · 2024 · Elsevier eBooks
27. Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review
    Han Yu, Zhijun Wang, Gang Zhao · 2024 · Pharmacognosy Magazine
28. Immune cell balance as potential biomarker of progressing non-alcoholic fatty liver disease
    Ludmila V. Topchieva, Курбатова Ирина Валерьевна, Ольга Петровна Дуданова, Alina Vasileva, Г. А. Жулай · 2024 · Genes and Cells
29. PDE5 inhibition mitigates heart failure in hyperlipidemia
    Wuqing Huang, Xi Yang, Naiqi Zhang, Keyuan Chen, Jun Xiao, Zhihuang Qiu, Sujun You, Ziting Gao, Jianguang Ji, Liangwan Chen · 2024 · Biomedicine & Pharmacotherapy
30. Histopathological manifestations of liver tissue affected by heated and unheated palm oil in male Wistar rats
    Maryam Ahookhash, Mohammad‐Taher Moradi, Mohsen Zhaleh · 2024 · Morphologie
31. A comparative study on the effect of melatonin and orlistat combination versus orlistat alone on high fat diet-induced hepatic changes in the adult male albino rats (a histological and morphometric study)
    Sayed El-Sayed, Gehan A. El-Sayed, Mansour M.A, Enas Haridy Ahmed, Sherif A. Kamar · 2024 · Ultrastructural Pathology
32. Metabolic Syndrome and Related Liver Diseases
    Aymin Delgado‐Borrego · 2012 · Springer eBooks
33. Non-Alcoholic Fatty Liver Disease (NAFLD): The Lipid Disease of the Liver and the Effect of Statins
    Mazen Noureddin, David Alexanian, Neil Kaplowitz · 2015 · Springer eBooks
34. Vitamin E Treatment for Patients with Nonalcoholic Steatohepatitis
    Jhonathan Ferney Vélez M, Gustavo Amador Crespo H, Juan Carlos Restrepo · 2014 · Revista Colombiana de Gastroenterología
35. Influence of α-lipoic acid on morphology of organs of rabbits fed a high fat diet with the addition of oxidised rapeseed oil
    Barbara Stawiarska-Pięta, Jolanta Zalejska–Fiolka, Magdalena Wyszyńska, Anna Kleczka, Beata Janiga, Natalia Grzegorzak, Ewa Birkner · 2017 · Journal of Veterinary Research
36. Blood-Based Novel Biomarkers for Nonalcoholic Steatohepatitis
    Yun Qiu, Sufan Wang, Ting Wan, Mingtong Ye, Rui Jiang, Lei Pei, Lili Yang · 2018 · Biomarkers in Medicine
37. Adult Non-alcoholic Fatty Liver Disease (NAFLD)
    Julie Steen Pedersen, Flemming Bendtsen · 2018 · Springer eBooks
38. From fatty liver to nonalcoholic steatohepatitis with fibrosis
    Pablo Muriel · 2022 · Elsevier eBooks
39. A novel role of RNase L in the development of nonalcoholic steatohepatitis
    Guanmin Chen, Xiaotong Zhao, Maksym Dankovskyy, Abigail Ansah-Zame, Uthman M. Alghamdi, Danting Liu, Ruhan Wei, Jianjun Zhao, Aimin Zhou · 2023 · The FASEB Journal
40. Toward a Mechanistic Understanding of Hepatic Insulin Action and Resistance
    Joshua R. Cook · 2014
41. What is Non‐Alcoholic Fatty Liver Disease (NAFLD), and Why is it Important?
    Geoffrey C. Farrell, Arthur J. McCullough, Christopher Paul Day · 2013
42. The contribution of vascular adhesion protein-1 to glucose and lipid homeostasis in the liver
    Sumera Karim · 2013 · University of Birmingham Institutional Research Archive (University of Birmingham)
43. Caracterización del papel de la ácido graso translocasa CD36 en la enfermedad hepática grasa no alcohólica y en la hepatitis crónica por virus C
    Miguel Fernández‐Bermejo · 2014 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
44. Hfe-associated steatohepatitis: expression profiling and identifying the molecular basis of liver injury
    Nishreen Santrampurwala · 2016 · The University of Queensland
45. The Cellular Pathways of Liver Fibrosis in NASH
    Nahúm Méndez‐Sánchez, Carlos Esteban Coronel-Castillo, Jocelyn Contreras-Carmona, Beatriz Barranco-Fragoso, Xingshun Qi · 2019 · Preprints.org
46. Non‐alcoholic Fatty Liver Disease
    Yaron Rotman, Devika Kapuria · 2020
47. Lipotoxicity in Non-alcoholic Fatty Liver Disease: Mechanisms and Prevention in Experimental Models
    Yana Geng · 2020
48. Efectos de la sobrecarga de colesterol sobre la función Mitocondrial y la producción de especies reactivas de oxigenó. Papel del factor de crecimiento de hepatocitos sobre el control del estrés oxidante
    Mayra Domínguez‐Pérez · 2016
49. Author response: FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis
    Cong Liu, Milena Schönke, Borah Spoorenberg, Joost M. Lambooij, Hendrik J.P. van der Zande, Enchen Zhou, Maarten E. Tushuizen, Anne‐Christine Andréasson, Andrew Park, Stephanie N. Oldham et al. · 2023 · eLife
50. Roles of ABCG5 ABCG8 cholesterol transporter in lipid homeostasis
    Yuhuan Wang · 2015 · UKnowledge (University of Kentucky)
51. Manage non-alcoholic fatty liver disease using lifestyle interventions, as evidence for the use of pharmacological options is limited
    Adis Medical Writers · 2013 · Drugs & Therapy Perspectives
52. Efeito anti-fibrogênico do doador de óxido nítrico S-nitroso-N-acetilcisteína (SNAC) na esteato-hepatite não alcóolica experimental
    Daniel Ferraz de Campos Mazo · 2012 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
53. ESTUDIO DE LOS MECANISMOS PATOGÉNICOS DE LA HEPATITIS C Y SU RELACIÓN CON EL DESARROLLO DE ESTEATOSIS. EFECTO DE UN TRATAMIENTO ANTIOXIDANTE CON FLAVONOIDES
    Sandra Pisonero‐Vaquero · 2014 · Dialnet (Universidad de la Rioja)
54. Studies on the mechanisms of action and physiological relevance of SOCS proteins
    Fahad Zadjali · 2011 · Figshare
55. Endoplasmic Reticulum Stress and Lipophagy in Nonalcoholic Steatohepatitis
    Jian Wu, Xizhong Shen · 2014 · eScholarship (California Digital Library)
56. The Role of Systemic Inflammation in the Development of Equine Laminitis
    Elizabeth M. Tadros · 2011
57. New Paradigms in the Histopathology of NAFLD
    Andrew Donald Clouston, Victoria L. Gadd, Katharine M. Irvine, Elizabeth Ellen Powell · 2014 · Current Hepatology Reports
58. Metabolic aspects of cardiac arrhythmias
    Sigfús Gizurarson · 2012 · Gothenburg University Publications Electronic Archive (Gothenburg University)
59. Stop or Click Mechanism in the Animal Kingdom.
    Otto Thilo · 1901 · Europe PMC (PubMed Central)
60. Tratamiento con vitamina E en pacientes con esteatohepatitis no alcohólica Vitamin E Treatment for Patients with Nonalcoholic Steatohepatitis
    Jhonathan Ferney Vélez M, María José Vega Vélez, Gustavo Álvarez Amador, Juan Carlos, Guillermo Restrepo · 2014
61. Critical Evaluation for Alternative Causes of Drug Induced and Herbal Induced (DILI/HILI) Hepatotoxicity
    Vasilios H. Frankos, Raushanah Najeeullah, Joel Morgan · 2016 · Health
62. Fatty Liver Disease: A Wake Up Call
    HAM Nazmul Ahasan, Chandra Shekhar Bala, Sarmistha Biswas, Baharul Minnat, Homayra Tahseen Hossain · 2016 · Bangladesh Journal of Medicine
63. How to best diagnose NAFLD/NASH?
    Vlad Ratziu · 2016
64. Deregulation of fatty acid metabolism and cannabinoid receptors in liver of morbidly obese women with non-alcoholic fatty liver disease
    Alba Berlanga · 2015 · TDX (Tesis Doctorals en Xarxa)
65. Nonalcoholic Fatty Liver Disease in Children: Role of the Gut Microbiota
    Ding‐You Li, Min Yang, Sitang Gong, Shui Qing Ye · 2016 · InTech eBooks
66. Cholesterol Plays a Crucial Role in High-fat-diet Induced ER stress and Non-alcoholic Fatty Liver Disease
    Amir Bashiri · 2014 · TSpace (University of Toronto)
67. Patologiniu nutukimu sergančių pacientų kepenų histologinių pokyčių vertinimas
    Karolis Čekas, Gintautas Brimas, Arvydas Laurinavičius, Aušrinė Barakauskienė · 2012 · Lietuvos chirurgija
68. Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
    Thomas E. Akie · 2015 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
69. Stress-activated MIG6 compromises hepatic metabolism during diet-induced obesity
    Andrew J. Lutkewitte · 2016 · IUScholarWorks (Indiana University)
70. Diabetes and Non‐Alcoholic Fatty Liver Disease
    Shivakumar Chitturi, Geoffrey C. Farrell · 2016
71. Cardiovascular disease and all-cause mortality : influence of fitness, fatness and genetic factors
    Gabriel Högström · 2017 · DiVA at Umeå University (Umeå University)
72. Perinatal programming of metabolic dysfunction and obesity-induced inflammation
    Camilla Ingvorsen, Lars Ingvar Hellgren, Susanne Brix · 2013
73. Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes
    Kenneth J. Cusi · 2017 · Contemporary diabetes
74. Comparación de los factores de riesgo cardiovascular, adipocitoquinas, antropometría e ingesta dietética de pacientes obesos con ALT/GPT alterada frente a pacientes obesos con ALT/GPT normal
    María Lizett Martínez Correa · 2017
75. The lipidomics of non-alcoholic fatty liver disease : from in vitro to human studies
    Kang‐Yu Peng · 2017 · Minerva Access (University of Melbourne)
76. Non-alcoholic Fatty Liver Disease: What We Learn from Omics Studies
    Şeyma Katrinli, Kâmil Özdil, Gizem Dinler Doğanay, Hamdi Levent Doğanay · 2018 · InTech eBooks
77. The role of MRI in stratifying and evaluating chronic liver disease
    Peter J. Eddowes · 2018 · University of Birmingham Institutional Research Archive (University of Birmingham)
78. The Role of Palmitoleate in Hypertension and Cardiac Hypertrophy
    Suresh C. Bairwa · 2017 · ERA: Education and Research Archive (University of Alberta)
79. A34 EFFECT OF AUTOPHAGY INDUCTION VIA TRPML1 ACTIVATION ON HEPATIC STEATOSIS
    Claudia Tersigni, Mariana Capurro, Sonya A. MacParland, Nazia Selzner-Malekkiani, Nicola L. Jones · 2019 · Journal of the Canadian Association of Gastroenterology
80. Effects of Imidacloprid in the Development of Non-Alcoholic Fatty Liver Disease and the Effects of Exercise Training
    Gabriel Jolin-Rodrigue · 2019 · uO Research (University of Ottawa)
81. The role of folate in non-alcoholic fatty liver disease
    Victoria Sid · 2019 · Mspace (University of Manitoba)
82. Obesity-induced hepatic changes during pregnancy
    Luís F. Grilo · 2019 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
83. Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?
    Emad Hamdy Gad, Yasmin Kamel · 2019 · IntechOpen eBooks
84. Retraction Note: Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
    Jae Young Yu, Hanh Thuy Nguyen, Chul Soon Yong, Hyoung Geun Park, Joon Ho Jun, Jong Oh Kim · 2020 · Laboratory Animal Research · Retracted
85. Role of extracellular vesicles in hypoxia-induced hepatic injury in non-alcoholic fatty liver disease
    Alejandra Hernández Villanueva · 2021
86. Soluble mannose receptor induces pro-inflammatory macrophage activation and metaflammation
    Maria Embgenbroich, Hendrik J.P. van der Zande, Leonie Hussaarts, Jonas Schulte-Schrepping, Leonard R. Pelgrom, Noemí García-Tardón, Laura Schlautmann, Isabel Stoetzel, Kristian Händler, Joost M. Lambooij et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
87. Pharmacological Options for NASH
    Christiane Stern, Vlad Ratziu · 2020 · Springer eBooks
88. Multi-Omic Predictors of Steatohepatitis and Advanced Fibrosis in Children
    Kattayoun Kordy, Fan Li, David J. Lee, Jason Michael Kinchen, Michael Jew, Maria Eduarda La Rocque, Sofía Martínez, Sara Zabih, Monica Saavedra, Cora L. Woodward et al. · 2019 · SSRN Electronic Journal
89. Focus on the Type 2 Diabetes Patient with Liver Disease: Emphasis on Nonalcoholic Fatty Liver Disease (NAFLD)
    Kenneth J. Cusi · 2011 · Endocrine Practice
90. Searching for biomarkers of non-alcoholic fatty liver disease and metabolic syndrome
    Laura delaCruz‐Villar · 2020 · Communities in ADDI (University of the Basque Country)
91. Nhận xét tình trạng đề kháng insulin trên bệnh nhân gan nhiễm mỡ
    Diễm Quỳnh Phan, Trung Quân Đỗ · 2021 · Vietnam Journal of Diabetes and Endocrinology
92. Future of pharmacological treatment of non-alcoholic steatohepatitis in terms of key pathophysiological mechanisms
    Marek Rác, Ľubomír Skladaný · 2018 · Vnitřní lékařství
93. Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis
    Peter Michael Abuja, Kurt Zatloukal, Helmut Denk · 2021 · International Journal of Molecular Sciences
94. Efecto del cadmio en la progresión del daño hepático en esteatosis
    Diana Patricia Rosales Cruz · 2014
95. Evaluación del efecto del factor de crecimiento de hepatocitos (HGF) en el estado REDOX celular en cultivo de hepatocitos de ratón alimentados con una dieta hipercolesterolémica
    Mayra Domínguez‐Pérez · 2011
96. Influencia de la nicotinamida en la síntesis de ácidos grasos de novo en hígado graso: participación de la glucosa -6- fosfato deshidrogenasa
    Selene Ángeles Mejía · 2018
97. PATHOGENESIS AND NUTRITIONAL REGULATION OF FATTY LIVER HEMORRHAGE SYNDROME IN LAYING HENS
    2022 · International Journal of Veterinary Science
98. Advances in Lipotoxicity Research on Hepatocellular Carcinoma
    Quanjun Wang · 2022 · Open Access Journal of Toxicology
99. ON THE ROLE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN THE DEVELOPMENT OF ATHEROSCLEROSIS: CARDIOVASCULAR RISK AND PATHOPHYSIOLOGICAL MECHANISMS
    Aleksey Michailovich Chaulin, Yu.V. Grigoreva, G.N. Suvorova · 2022 · Научное обозрение Медицинские науки (Scientific Review Medical Sciences)
100. Lower adiposity does not protect beta-2 syntrophin null mice from hepatic steatosis and inflammation in experimental non-alcoholic steatohepatitis
     Lisa Rein‐Fischboeck, Rebekka Pohl, Elisabeth M. Haberl, Wolfgang Mages, Philipp Girke, Gerhard Liebisch, Sabrina Krautbauer, Christa Buechler · 2023 · Gene